Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease
Back
9 Feb 2025
9:18 a.m.
9:36 a.m.
Vlado
Perkovic
Oral Abstract Presenter
Australia
University of New South Wales, Sydney, Australia